Cited by 526Bipolar Disorder and TreatmentGenetic Associations and EpidemiologySchizophrenia research and treatment

The bipolar disorder risk allele at CACNA1C also confers risk of recurrent major depression and of schizophrenia

Open access
Wellcome Trust Case Control Consortium, Green, E K, Grozeva, D, Jones, I, Jones, L, Kirov, G, Caesar, S, Gordon-Smith, K +12 more·2010·Molecular Psychiatry

Abstract

Molecular genetic analysis offers opportunities to advance our understanding of the nosological relationship between psychiatric diagnostic categories in general, and the mood and psychotic disorders in particular. Strong evidence (P=7.0 × 10(-7)) of association at the polymorphism rs1006737 (within CACNA1C, the gene encoding the α-1C subunit of the L-type voltage-gated calcium channel) with the risk of bipolar disorder (BD) has recently been reported in a meta-analysis of three genome-wide association studies of BD, including our BD sample (N=1868) studied within the Wellcome Trust Case Control Consortium. Here, we have used our UK case samples of recurrent major depression (N=1196) and schizophrenia (N=479) and UK non-psychiatric comparison groups (N=15316) to examine the spectrum of phenotypic effect of the bipolar risk allele at rs1006737. We found that the risk allele conferred increased risk for schizophrenia (P=0.034) and recurrent major depression (P=0.013) with similar effect sizes to those previously observed in BD (allelic odds ratio ∼1.15). Our findings are evidence of some degree of overlap in the biological underpinnings of susceptibility to mental illness across the clinical spectrum of mood and psychotic disorders, and show that at least some loci can have a relatively general effect on susceptibility to diagnostic categories, as currently defined. Our findings will contribute to a better understanding of the pathogenesis of major psychiatric illness, and such knowledge should be useful in providing an etiological rationale for shaping psychiatric nosology, which is currently reliant entirely on descriptive clinical data.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/mp.2009.49

Cites

30 of 30 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • An intronic SNP of CACNA1C (rs1006737) appears in multiple neuropsychiatric disorders, including ASD.

    “This effort has begun for an intronic SNP of CACNA1C (rs1006737) that crops up in multiple neuropsychiatric disorders (Ferreira et al., 2008; Green et al., 2010; Moskvina et al., 2009; Nyegaard et al., 2010), including ASD (Li et al., 2015).”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Wellcome Trust Case Control Consortium, Green, E. K., Grozeva, D., Jones, I., Jones, L., Kirov, G., Caesar, S., Gordon-Smith, K., Fraser, C., Forty, L., Russell, E., Hamshere, M. L., Moskvina, V, Nikolov, I., Farmer, A., McGuffin, P., Holmans, P. A., Owen, M. J., O'Donovan, M. C., & Craddock, N.
Affiliations
  • Cardiff University (GB)
  • University of Birmingham (GB)
  • King's College London (GB)
Corresponding author
Craddock, N
Venue
Molecular Psychiatry
Published
2009-07-21
Volume
15
Issue
10
Pages
1016-1022
ISSN
  • 1359-4184 (ISSN-L)
  • 1476-5578
OpenAlex
W2098525901
Cited by
526
References
30
Citations by year
2026: 13 · 2025: 12 · 2024: 10 · 2023: 21 · 2022: 25 · 2021: 40 · 2020: 24 · 2019: 33 · 2018: 29 · 2017: 36 · 2016: 33 · 2015: 30 · 2014: 39 · 2013: 56 · 2012: 40
FWCI
25.48
Type
journal article
Language
en
Open access
Locations
  • Molecular Psychiatry (publishedVersion, cc-by-nc-nd)
  • PubMed Central (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
  • Research Portal (King's College London) (submittedVersion)
  • University of Birmingham Research Portal (University of Birmingham) (submittedVersion)
Funders
  • Wellcome Trust
  • Medical Research Council
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Bipolar Disorder and Treatment
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
  • Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
Keywords
CACNA1C, rs1006737, bipolar disorder, recurrent major depressive disorder, schizophrenia, L-type calcium channels, genetic susceptibility, psychiatric classification, mood disorders, psychosis, shared genetic risk
MeSH terms
Adult, Alleles, Bipolar Disorder, Major Depressive Disorder, Female, Genotype, United Kingdom, Humans, Male, Middle Aged, Phenotype, Recurrence, Risk Factors, Schizophrenia, Calcium Channels, L-Type

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review